Feedback PLC Directorate Change (5680H)
08 June 2017 - 10:11PM
UK Regulatory
TIDMFDBK
RNS Number : 5680H
Feedback PLC
08 June 2017
8 June 2017
Feedback plc
("Feedback", the "Group" or the "Company")
Directorate Change
Feedback plc (AIM: FDBK), the medical imaging software company,
announces that Trevor Brown, has resigned as a Non-Executive
Director of Feedback, with immediate effect, in order to allow the
Company to move rapidly to the next stage in its development and to
devote more time to his other business interests.
The Company is pleased to announce the appointment of Timothy
Norris Irish as Non-Executive Director with immediate effect. Tim
Irish is a Professor of Practice at Kings College London as well as
a board member of Bournemouth University. Tim joined the board of
the National Institute for Health and Care Excellence (NICE) in
April 2015 and became the Senior Independent Director in May 2017.
Tim has worked in the life sciences industry for thirty years. His
career has spanned global health technology companies across Europe
and North America, including GSK, GE and Philips the latter two in
senior positions responsible for medical imaging. Tim also
currently holds a number of non-executive positions in health and
technology related entities.
Dr Alastair Riddell, Non-Executive Chairman, commented: "I
should like to thank Trevor for his invaluable support of the
Company following its readmission in 2014 which has enabled it to
achieve substantial progress to date.
We are delighted to announce the appointment of Tim Irish as a
non-executive director. Tim's experience and sector knowledge will
strengthen the Board and assist the Company through its next
significant growth phase."
Trevor Brown, said: "It has been a pleasure to see Feedback
develop over the last three years. The Company is about to embark
on an exciting stage of its development and it is an appropriate
time for me to step down to allow Alastair and the board scope to
appoint directors with relevant industry experience and take the
Company to the next level. I have indicated to the board that I am
preparing to enter into an orderly market agreement in respect of
my substantial shareholding, so as not to adversely affect the
Company's share price going forward.
Tim Irish commented: "I am delighted to be joining the Board of
Feedback at this exciting time in the Company's development. I have
been impressed with Feedback's current technology offering, and I
see great future potential for advanced imaging analytics to
significantly improve patient outcomes."
For further information contact:
Feedback plc Tel: 01954 718072
Dr Alastair Riddell
Allenby Capital Limited (Nominated Tel: 020 3328 5656
Adviser and Joint Broker)
David Worlidge / Virginia
Bull / James Thomas
Northland Capital Partners Tel: 020 3861 6625
Ltd (Joint Broker)
Patrick Claridge / Margarita
Mitropoulou
Peterhouse Corporate Finance Tel: 020 7469 0936
Ltd (Joint Broker)
Lucy Williams / Duncan Vasey
Regulatory Disclosures
In accordance with Rule 17 and Schedule 2(g) of the AIM Rules
for Companies, Timothy Norris Irish, aged 52 is, or has been within
the last five years, a director or partner in the following
companies and partnerships:
Current directorships Past directorships and
and partnerships partnerships held within
the last five years
Quirem Medical BV FlexGen BV
Fiagon AG Bmeye BV
CfBT Schools Trust Mendor Oy
Pembrokeshire Retreats Nexstim plc
Ltd
TTS Pharma Ltd
Bioxydyn Limited
Input Ideal Ltd
Computabound Ltd
Patech Solutions Ltd
Deltex plc
There is no other information required to be disclosed under the
AIM Rules for Companies.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAFPMTTMBBMBMR
(END) Dow Jones Newswires
June 08, 2017 08:11 ET (12:11 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
From Mar 2024 to May 2024
Feedback (LSE:FDBK)
Historical Stock Chart
From May 2023 to May 2024
